Evidence map›Paper›PMID 8605097›Full record

ArticleBritish journal of cancer1996

Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.

N Yamada, M Kato, P ten Dijke, H Yamashita, T K Sampath, C H Heldin, K Miyazono, K Funa

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.International journal of biological sciences · 2010
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

N YamadaLudwig Institute for Cancer Research, Uppsala, Sweden.
M Kato
P ten Dijke
H Yamashita
T K Sampath
C H Heldin
K Miyazono
K Funa
Ludwig Cancer Research · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The distribution of bone morphogenetic protein (BMP) type I receptors and the activin type I receptor (ActR-I) was investigated in 16 cases of human glioma and five cases of non-tumourous gliosis tissue by immunohistochemical technique. Both BMP type IA (BMPR-IA) and the type IB (BMPR-IB) receptors were detected in human glioma cells. A significant increase in BMPR-IB in tumour cells was observed in malignant glioma compared with both low-grade astrocytomas (n=16, P<0.005) and gliosis (n=13, P<0.001). However, enhancement of BMPR-IA staining was moderate and ActR-I staining was only weakly expressed in the malignant glioma tumours. Osteogenic protein (OP)-1/BMP-7, which is known to bind BMPR-IA, BMPR-IB and ActR-I, was expressed in nervous tissue and was also detected in anaplastic areas of malignant glioma. In contrast to the tissue materials, BMPR-IA was expressed to a stronger degree than BMPR-IB in human glioma cell lines; the growth of these cells was suppressed by OP-1. These results suggest the presence of BMP receptors and a functional role for BMPs in malignant glioma.

Indexed as

Bone Morphogenetic ProteinsTransforming Growth Factor betaActivin ReceptorsAnimalsBone Morphogenetic Protein 7Bone Morphogenetic Protein ReceptorsBone Morphogenetic Protein Receptors, Type IGliomaHumansImmunohistochemistryProteinsRabbitsReceptors, Cell SurfaceReceptors, Growth FactorTumor Cells, CulturedActivin ReceptorsBMP7 protein, humanBMPR1A protein, humanBMPR1B protein, humanBone Morphogenetic Protein 7Bone Morphogenetic Protein ReceptorsBone Morphogenetic Protein Receptors, Type IBone Morphogenetic ProteinsProteinsReceptors, Cell SurfaceReceptors, Growth FactorTransforming Growth Factor beta

Identifiers

PMID8605097
PMCPMC2074358
OpenAlexW2070682474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.